F
Frank Møller Aarestrup
Researcher at Technical University of Denmark
Publications - 491
Citations - 46040
Frank Møller Aarestrup is an academic researcher from Technical University of Denmark. The author has contributed to research in topics: Antibiotic resistance & Salmonella. The author has an hindex of 101, co-authored 462 publications receiving 37509 citations. Previous affiliations of Frank Møller Aarestrup include University of Copenhagen & European Union.
Papers
More filters
Journal ArticleDOI
Evaluating the usefulness of next-generation sequencing for herb authentication
TL;DR: In this article, the authors developed a customised database and bioinformatics pipeline (Herbs Authenticity - GitHub) to identify herbal ingredients implemented as a metagenomics approach for plant-derived product authenticity testing.
Journal ArticleDOI
External quality assurance system (EQAS) for identification of mastitis pathogens in Denmark from 2006 to 2011
Susanne Karlsmose,L. Kunstmann,Carsten Friis Rundsten,Kaspar Krogh,H. D. Larsen,Arne Bent Jensen,Frank Møller Aarestrup,Rene S. Hendriksen +7 more
TL;DR: The results from this study indicate that the practices' application of basic biochemical analyses in this context could be optimized and thereby to assist veterinary practices at strengthening their mastitis diagnostics.
Journal ArticleDOI
Vigilância da resistência aos antimicrobianos no homem, nos produtos alimentares e no gado na Dinamarca
TL;DR: A resistencia crescente das bacterias patogenicas aos antimicrobianos tem causado preocupacao, em todo o mundo, de that uso generalizado de agentes antimicro Bianos na producao animal possa promover o desenvolvimento de bacterias resistentes ou de genes da resistencia.
Journal ArticleDOI
Commentary: Benefits and risks of antimicrobial use in food-producing animals
TL;DR: It is suggested that the continued improvement in productivity in the Danish pig sector is partially explained by improved animal management through increased veterinary oversight (while veterinarians in Denmark since 1995 were legally banned from making a direct profit from sales of antimicrobials).